Back to trial details

Intake questionnaire

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Applying to TrialSphere Corp · Chandler, Arizona

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 55 and 90 years old?
2. Have you been diagnosed with Alzheimer's Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chandler for study visits?